Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00452179 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of APD125 in Patient With Insomnia
A Phase 2 study of Insomnia, sponsored by Arena Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 173
- Enrollment target
- 1
- Study location
NCT00452179: Completed Phase 2 study of Insomnia, sponsored by Arena Pharmaceuticals.
NCT00452179 is a Phase 2 study of Insomnia that has completed, run by Arena Pharmaceuticals. The registered enrollment target is 173 participants, roughly in line with the 169-participant average among 151 other Insomnia trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00452179, a Phase 2 study of Insomnia, has completed, sponsored by Arena Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 173 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effects of APD125 in patients with sleep maintenance insomnia.
Conditions Studied
Interventions
- DRUG APD125
Study Locations (1)
California
- - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 2007-02 |
| Est. Completion | 2007-06 |
| Phase | Phase 2 |
What the finished NCT00452179 record still lists
NCT00452179 is an interventional study that assigns participants to a tested intervention. The registered 173 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 169-participant average among 151 other Insomnia trials with a reported enrollment target.
The record links to 1 condition, with Insomnia appearing as the primary indexed condition, and to 1 intervention - of which APD125 is the first listed.
NCT00452179 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00452179 about?
NCT00452179 is a clinical study titled "Safety and Efficacy Study of APD125 in Patient With Insomnia". The purpose of this study is to determine the effects of APD125 in patients with sleep maintenance insomnia.
What is the current status of trial NCT00452179?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 173 participants. The study started on 2007-02. Estimated completion is 2007-06.
What conditions does trial NCT00452179 study?
This clinical trial studies the following conditions: Insomnia.
What interventions are being tested in trial NCT00452179?
The interventions under investigation include: APD125 (DRUG).
Who is sponsoring clinical trial NCT00452179?
This trial is sponsored by Arena Pharmaceuticals, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00452179 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00452179's enrollment target sits among peer trials
173 41st of 151 higher than 111 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
Pimavanserin for Insomnia in Veterans With PTSD
RECRUITING · Phase 2
-
Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse
RECRUITING · Phase 2
-
Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
RECRUITING · Phase 2
-
Suvorexant for Treatment of AUD and PTSD
RECRUITING · Phase 2
-
Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05568719 · 173 participants · Phase 3
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- NCT07070115 · 173 participants · NA
Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®
- NCT07150832 · 173 participants · NA
Efficacy of the I-CARE Digital Health Intervention
- NCT01000259 · 174 participants
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia